DISTRIBUTOR REPORTING. (a) Distributor shall comply with the requirements of Nasdaq as to reporting of Reportable Units as set forth in this Agreement and the Nasdaq Requirements. Unless otherwise set forth in the Nasdaq Requirements, Distributor shall use reasonable efforts to provide such reporting within fifteen (15) days of the end of the applicable reporting period set forth by Nasdaq in the Nasdaq Requirements but Nasdaq shall not consider such reporting to be late until forty-five (45) days after the due date.
(b) Distributor is limited to a sixty (60) calendar-day grace period in which to revise or correct its original usage reporting in order to obtain retroactive credits. The grace period begins on the due date of the original usage report, but is extended to the next business day if the last day of the grace period coincides with a market holiday or weekend day. Nasdaq will not provide Distributor with back credits for original or revised reporting received after the end of the grace period. Revised reporting could include, but is not limited to, reclassification of Recipients or Reportable Units, reporting of usage under alternative pricing structures and correction of errors by Distributor. This Section 6 does not limit Distributor's liability to Nasdaq for underreporting of usage.
DISTRIBUTOR REPORTING. DISTRIBUTOR shall complete a series of regular reports as described in Attachment F hereto. The reports are due no later than the 10th day of each month following the end of the respective reporting periods and shall constitute Confidential Information of DISTRIBUTOR. The Parties acknowledge that Applicable Laws or existing contractual relationships with Third-Party Payers may restrict DISTRIBUTOR’s ability to collect, use, include and/or disclose as Data certain patient, payer, and physician-specific data. DISTRIBUTOR shall not provide patient, payer, and physician-specific data and information where so limited by such existing contractual relationships or Applicable Laws. New contracts with Third Party Payers or the enactment of new Applicable Laws may further limit the disclosure of patient- and physician-specific data and information. Neither Party may resell data to IMS, Wolters Kluwer, or any other data aggregation service .
DISTRIBUTOR REPORTING. (a) Distributor shall comply with the requirements of NASDAQ OMX as to reporting of Reportable Units as set forth in this Agreement and the NASDAQ OMX Requirements. Unless otherwise set forth in the NASDAQ OMX Requirements, such reporting shall occur within fifteen (15) days of the end of the applicable reporting period set forth by NASDAQ OMX in the NASDAQ OMX Requirements.
(b) Distributor is limited to a sixty (60) calendar-day grace period in which to revise or correct its usage reporting in order to obtain retroactive credits. The grace period begins on the due date of the original report, but is extended to the next business day if the last day of the grace period coincides with a market holiday or weekend day. NASDAQ OMX will not provide Distributor with back credits for original or revised reporting received after the end of the grace period. Revised reporting could include, but is not limited to, reclassification of Recipients or Reportable Units, reporting of usage under alternative pricing structures and correction of errors by Distributor. This Section 6 does not limit Distributor's liability to NASDAQ OMX for underreporting of usage.
DISTRIBUTOR REPORTING. DISTRIBUTOR shall complete a series of regular reports as described in Attachment F hereto. The reports are due no later than the 10th of each month following the end of the respective reporting periods and constitute Confidential Information of DISTRIBUTOR. The Parties acknowledge that Applicable Laws or existing contractual relationships with Third-Party Payers may restrict DISTRIBUTOR’s ability to collect, use, include and/or disclose as Data certain patient- and physician-specific data. DISTRIBUTOR warrants that it will not provide patient- and physician-specific data and information where so limited by such existing contractual relationships or Applicable Laws. New contracts with Third Party Payers and the enactment of new Applicable Laws which further limit the disclosure of patient- and physician-specific data and information shall not be deemed to be a change in a law for purposes of this Agreement. Neither Party may resell data to IMS, Wolters Kluwer, or any other data aggregation service without the express written consent of the other Party.
DISTRIBUTOR REPORTING. Distributor will report the number of Recipients obtaining Information through the Distributor’s System each month within fifteen (15) days following the calendar end of the applicable month through the reporting service specified by OTC Markets Group, which may be changed from time to time. Distributor shall report the number of Professional Subscribers and Non-Professional Subscribers obtaining the Information. Notwithstanding the foregoing, the Distributor is not required to report the number of Recipients in the case of (i) Information distributed pursuant to a Broker-Dealer License, (ii) Derived Data Usage of the Information, or (iii) Internal Display Usage or External Display Usage of Delayed Data. Non-Display and Derived Data Usage Declaration. Distributor receiving an Uncontrolled Data Feed must declare their Non-Display and Derived Data Usage to OTC Markets Group on an annual basis, by January 31 of each year, or more frequently upon request by OTC Markets Group, by completing the OTC Markets Non-Display and Derived Data Usage Declaration. In the event that Distributor’s use of the Information is or becomes inconsistent with the Non-Display and Derived Data Usage Declaration, Distributor agrees to promptly notify OTC Markets Group and submit a revised declaration for approval by OTC Markets Group.
